Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Penumbra, Inc.
PEN
$318.89
Name : Penumbra, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $12,560,893,952.00
EPSttm : 4.08
finviz dynamic chart for PEN
Penumbra, Inc.
$318.89
0.26%
$0.83
PEN — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

4.72

Margin Of Safety %

-13

Put/Call OI Ratio

2.07

EPS Next Q Diff

0.61

EPS Last/This Y

0.22

EPS This/Next Y

1.34

Price

318.9

Target Price

363.29

Analyst Recom

2.8

Performance Q

0.7

Upside

-55.3%

Beta

0.7

Ticker: PEN




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-08-28PEN321.842.1513.0011792
2026-08-31PEN323.242.161.5811816
2026-09-01PEN322.712.1535.5011841
2026-09-02PEN322.852.16999.9911878
2026-09-03PEN321.32.1720.5011931
2026-09-04PEN322.192.18999.9911966
2026-09-08PEN319.332.197.2711999
2026-09-09PEN319.542.2068.0012070
2026-09-10PEN317.832.226.5212126
2026-09-11PEN317.82.25999.9912320
2026-09-14PEN320.032.26999.9912347
2026-09-15PEN318.512.2670.0012373
2026-09-16PEN318.732.28999.9912440
2026-09-17PEN318.782.2921.0012482
2026-09-18PEN317.52.300.3312502
2026-09-21PEN318.742.112.3812267
2026-09-22PEN319.392.11206.0012355
2026-09-23PEN319.352.12999.9912403
2026-09-24PEN319.712.10464.0012324
2026-09-25PEN318.952.0713.0012220
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-08-28PEN321.6421.927.44.79
2026-08-31PEN323.1221.927.94.79
2026-09-01PEN322.5821.926.54.79
2026-09-02PEN322.7921.967.14.79
2026-09-03PEN321.3721.965.64.79
2026-09-04PEN322.1821.967.64.79
2026-09-08PEN319.3621.964.44.79
2026-09-09PEN319.7121.967.14.79
2026-09-10PEN317.8221.965.34.79
2026-09-11PEN317.7821.967.04.79
2026-09-14PEN320.0521.968.94.79
2026-09-15PEN318.4221.965.64.79
2026-09-16PEN318.4221.965.64.79
2026-09-17PEN318.8221.967.24.79
2026-09-18PEN317.5621.965.74.79
2026-09-21PEN318.7421.967.94.79
2026-09-22PEN319.3321.967.34.79
2026-09-23PEN319.2221.966.74.79
2026-09-24PEN319.7821.967.24.79
2026-09-25PEN318.9021.966.14.79
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-08-28PEN-0.220.844.76
2026-08-31PEN-0.220.754.76
2026-09-01PEN-0.220.754.76
2026-09-02PEN-0.220.754.76
2026-09-03PEN-0.220.754.76
2026-09-04PEN-0.220.754.76
2026-09-08PEN-0.011.014.76
2026-09-09PEN-0.011.014.76
2026-09-10PEN-0.011.014.76
2026-09-11PEN-0.011.014.53
2026-09-14PEN-0.011.064.53
2026-09-15PEN-0.011.064.53
2026-09-16PEN-0.011.064.53
2026-09-17PEN-0.011.064.53
2026-09-18PEN-0.011.064.53
2026-09-21PEN-0.011.054.53
2026-09-23PEN-0.011.054.53
2026-09-24PEN-0.011.054.53
2026-09-25PEN-0.011.054.72
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

0.88

Avg. EPS Est. Current Quarter

1.18

Avg. EPS Est. Next Quarter

1.49

Insider Transactions

-0.01

Institutional Transactions

1.05

Beta

0.7

Average Sales Estimate Current Quarter

400

Average Sales Estimate Next Quarter

428

Fair Value

277.63

Quality Score

94

Growth Score

99

Sentiment Score

95

Actual DrawDown %

12

Max Drawdown 5-Year %

-59.7

Target Price

363.29

P/E

78.3

Forward P/E

53.23

PEG

2.41

P/S

8.35

P/B

8.2

P/Free Cash Flow

58.17

EPS

4.07

Average EPS Est. Cur. Y​

4.79

EPS Next Y. (Est.)

6.13

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.67

Relative Volume

0.64

Return on Equity vs Sector %

-15.8

Return on Equity vs Industry %

-1

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

-0.17

EBIT Estimation

66.1
◆ PEN Healthcare
$318.84
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
23/25
Volume
9/15
Valuation
9/20
TP/AR
0/10
Options
0/10
RSI
44.1
Range 1M
27.5%
Sup Dist
0.1%
🚀
Momentum Growth
Ride accelerating trends
N/A
34 /100
WEAK
Momentum
10/25
Growth
13/30
Estimates
6/20
Inst/Vol
5/15
Options
0/10
EPS Yr
22.6%
EPS NY
27.2%
52W%
69.3%
💎
Long-Term Value
Quality companies, undervalued
39 /100
WEAK
🔴 SELL -17.4% upside
Quality
14/30
Valuation
0/30
Growth
14/25
Stability
8/10
LT Trend
3/5
Upside
-17.4%
Quality
94
MoS
-13%
PEN — P/E HistoricalMedical Devices
Penumbra, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 4700
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
PEN

Latest News

—
Caricamento notizie per PEN…
stock quote shares PEN – Penumbra, Inc. Stock Price stock today
news today PEN – Penumbra, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PEN – Penumbra, Inc. yahoo finance google finance
stock history PEN – Penumbra, Inc. invest stock market
stock prices PEN premarket after hours
ticker PEN fair value insiders trading